Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MED
Upturn stock ratingUpturn stock rating

MEDIFAST INC (MED)

Upturn stock ratingUpturn stock rating
$13.14
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

04/01/2025: MED (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -48.02%
Avg. Invested days 19
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 04/01/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 149.41M USD
Price to earnings Ratio 71.89
1Y Target Price 15.75
Price to earnings Ratio 71.89
1Y Target Price 15.75
Volume (30-day avg) 233624
Beta 1.17
52 Weeks Range 12.87 - 36.30
Updated Date 04/2/2025
52 Weeks Range 12.87 - 36.30
Updated Date 04/2/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.19

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 0.35%
Operating Margin (TTM) 0.6%

Management Effectiveness

Return on Assets (TTM) 3.24%
Return on Equity (TTM) 1.02%

Valuation

Trailing PE 71.89
Forward PE -
Enterprise Value -2495914
Price to Sales(TTM) 0.25
Enterprise Value -2495914
Price to Sales(TTM) 0.25
Enterprise Value to Revenue 0.08
Enterprise Value to EBITDA 1.34
Shares Outstanding 10937800
Shares Floating 9494353
Shares Outstanding 10937800
Shares Floating 9494353
Percent Insiders 3.82
Percent Institutions 83.11

Analyst Ratings

Rating 3
Target Price 16.5
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold 2
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

MEDIFAST INC

stock logo

Company Overview

overview logo History and Background

Medifast, Inc. was founded in 1980. Initially focused on medical professionals, it evolved to a direct-selling model in the early 2000s with the Take Shape For Life program, later rebranded as OPTAVIA.

business area logo Core Business Areas

  • OPTAVIA: OPTAVIA is Medifast's primary business segment, offering weight management programs and products through a network of independent coaches.

leadership logo Leadership and Structure

Medifast is led by its CEO, Daniel R. Chard. The organizational structure includes departments for sales, marketing, product development, finance, and operations. Its direct-selling model relies heavily on independent OPTAVIA Coaches.

Top Products and Market Share

overview logo Key Offerings

  • OPTAVIA Fuelings: A variety of portion-controlled, nutrient-dense food products designed to support weight loss and maintenance. Medifast is reliant on this, however, it must contend with any food company that markets weight loss and healthy food diets such as Weight Watchers (WW), Nutrisystem (NTRI), Herbalife (HLF).
  • OPTAVIA Coaching Program: A program that connects clients with independent OPTAVIA Coaches who provide guidance and support. Medifast is reliant on this, however, it must contend with health and fitness coaches found on social media platforms like Youtube and Instagram.

Market Dynamics

industry overview logo Industry Overview

The weight management industry is driven by increasing obesity rates and a growing focus on health and wellness. The industry is highly competitive, with a mix of established players and new entrants.

Positioning

Medifast positions itself as a holistic weight management solution, combining meal replacements with coaching support. Its direct-selling model provides a network of coaches to support clients.

Total Addressable Market (TAM)

The global weight management market is estimated at hundreds of billions of dollars annually. Medifast targets a segment of this market focused on meal replacements and coaching, giving them access to a significant portion of the TAM.

Upturn SWOT Analysis

Strengths

  • Strong brand recognition within its niche
  • Large network of independent OPTAVIA Coaches
  • Recurring revenue model through fuelings
  • High customer satisfaction rates

Weaknesses

  • Reliance on independent coaches creates management challenges
  • Vulnerability to regulatory changes affecting the direct-selling industry
  • Product concentration; limited diversification
  • Relatively high price point compared to generic meal replacements

Opportunities

  • Expansion into new geographic markets
  • Development of new product lines targeting different health and wellness goals
  • Leveraging technology to enhance the coaching experience
  • Partnerships with healthcare providers

Threats

  • Increased competition from other weight management programs
  • Changes in consumer preferences towards alternative weight loss methods
  • Negative publicity or lawsuits related to the direct-selling model
  • Economic downturn affecting consumer spending on discretionary items

Competitors and Market Share

competitor logo Key Competitors

  • WW (WW)
  • Nutrisystem (NTRI)
  • Herbalife (HLF)
  • Beachbody (BODY)

Competitive Landscape

Medifast's advantages include its coaching model and brand reputation. Disadvantages include its higher price point and reliance on direct selling.

Major Acquisitions

Growth Trajectory and Initiatives

Historical Growth: Historical growth is heavily reliant on the success of OPTAVIA and the expansion of its coach network.

Future Projections: Future growth depends on Medifast's ability to attract new clients and coaches, retain existing ones, and expand into new markets. Analyst estimates vary depending on economic conditions and competitive dynamics.

Recent Initiatives: Recent initiatives include investments in technology to improve the coach-client experience, the introduction of new fueling products, and geographic expansion.

Summary

Medifast has established a strong position in the weight management industry through its OPTAVIA program. Its reliance on independent coaches creates both opportunities and challenges. Future growth will depend on its ability to innovate, adapt to changing consumer preferences, and manage its direct-selling model effectively.

Similar Companies

HLFratingrating

Herbalife Nutrition Ltd

$8.62
Small-Cap Stock
2.25%
Consider higher Upturn Star rating
BUY since 5 days

HLFratingrating

Herbalife Nutrition Ltd

$8.62
Small-Cap Stock
BUY since 5 days
2.25%
Consider higher Upturn Star rating

WWratingrating

WW International Inc

$0.54
Small-Cap Stock
0%
PASS

WWratingrating

WW International Inc

$0.54
Small-Cap Stock
0%
PASS

Sources and Disclaimers

Data Sources:

  • Company Filings
  • Industry Reports
  • Analyst Estimates

Disclaimers:

This analysis is for informational purposes only and does not constitute financial advice. Market share data is approximate and may vary. Financial data and shareholder returns were not retrieved due to API constraints and are necessary for an accurate report.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About MEDIFAST INC

Exchange NYSE
Headquaters Baltimore, MD, United States
IPO Launch date 1993-12-31
Executive Chairman & CEO Mr. Daniel R. Chard
Sector Consumer Cyclical
Industry Personal Services
Full time employees 504
Full time employees 504

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. It markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​